멀티오믹스 시장 : 규모, 점유율, 동향 분석, 제품 및 서비스별, 유형별, 플랫폼별, 용도별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Multiomics Market Growth & Trends:

The global multiomics market size is estimated to reach USD 9.81 billion by 2033, expanding at a CAGR of 15.33% from 2025 to 2033, according to a new report by Grand View Research, Inc. Factors such as the decreasing costs of omics technologies and growing investment and funding from private and public players are expected to drive the market. In addition, rising competition in the market owing to increasing demand from pharmaceutical & biotechnology companies and academic research institutions is also anticipated to propel the market growth over the forecast period.

With the improvement in technologies, the cost of omics technologies is anticipated to reduce, which can increase the accessibility of datasets to researchers, consequently driving market growth. Companies are focusing on technological advancements to lower costs. For instance, in November 2022, Amazon Web Services introduced an Amazon Omics service. This service utilizes bioinformatics-aware storage options to store raw sequence data and to decrease costs. Thus, the decreasing costs are anticipated to increase the accessibility of omics technologies to researchers and clinicians. Such cost reduction is expected to increase the adoption of multiomics approaches.

The growing investments and funding from private and public participants are anticipated to boost the demand for multi-omics products and services. Various companies are significantly investing in the development of multiomics platforms and technologies. For instance, in January 2022, Roche invested USD 290 million in Freenome, a biotech company. This investment was used to accelerate multiomics platforms for early cancer detection. In addition, in May 2023, MultiOmic Health completed a funding round of USD 6.2 million to construct a precision therapeutics discovery platform. Thus, the rising funding and investments are expected to develop various novel platforms and products in the markets

The rising emphasis of market players to develop innovative products and services is another vital factor propelling market demand forward. Various companies are developing novel platforms to sustain the rising competition. For instance, in February 2023, Via Scientific, Inc. introduced a multi-omics accelerator platform, Foundry, that supports the automation of complex data and analytical work during multi-omics research. Such product launches are anticipated to drive the industry over the forecast period.

Multiomics Market Report Highlights:

• Based on the product segment accounted for the largest market revenue share in 2024. The segment's growth is anticipated to be driven by the development surge and the number of product launches.
• Based on type, the bulk multiomics segment accounted for the largest market revenue share in 2024. In contrast, single-cell multi-omics is expected to grow at the fastest CAGR of 17.8% over the forecast period, due to increasing demand for single-cell multi-omics to comprehend complex biology systems
• Based on platform, genomics dominated the market with a revenue share of 40.63% in 2024. The growth is attributed to the high number of products available in this segment
• Based on application, the oncology segment accounted for the largest market revenue share in 2024. The rising incidence of cancer and the growing use of multi-omics for cancer are anticipated to drive segment growth.
• Based on end-use, the academic & research institutes segment accounted for the largest market revenue share in 2024. In contrast, pharmaceutical and biotechnology companies are expected to witness the fastest growth owing to increasing demand for multi-omics to accelerate drug discovery and development
• North America dominated the global industry in 2024 with a revenue share of 48. 76%, owing to the presence of key market players in the region

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product & Service
  • 1.2.2. Type
  • 1.2.3. Platform
  • 1.2.4. Application
  • 1.2.5. End-use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Multiomics Market: Product & Service Business Analysis

• 4.1. Segment Dashboard
• 4.2. Global Multiomics Market Product & Service Movement Analysis
• 4.3. Global Multiomics Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
• 4.4. Product
  • 4.4.1. Global Product Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Instruments
    • 4.4.2.1. Global Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Consumables
    • 4.4.3.1. Global Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. Software
    • 4.4.4.1. Global Software Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Services
  • 4.5.1. Global Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Multiomics Market: Type Business Analysis

• 5.1. Segment Dashboard
• 5.2. Global Multiomics Market Type Movement Analysis
• 5.3. Global Multiomics Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 5.4. Single-cell Multiomics
  • 5.4.1. Global Single-cell Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Bulk Multiomics
  • 5.5.1. Global Bulk Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Multiomics Market: Platform Business Analysis

• 6.1. Segment Dashboard
• 6.2. Global Multiomics Market Platform Movement Analysis
• 6.3. Global Multiomics Market Size & Trend Analysis, by Platform, 2021 to 2033 (USD Million)
• 6.4. Genomics
  • 6.4.1. Global Genomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Transcriptomics
  • 6.5.1. Global Transcriptomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Proteomics
  • 6.6.1. Global Proteomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Metabolomics
  • 6.7.1. Global Metabolomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Integrated Omics Platforms
  • 6.8.1. Global Integrated Omics Platforms Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Multiomics Market: Application Business Analysis

• 7.1. Segment Dashboard
• 7.2. Global Multiomics Market Application Movement Analysis
• 7.3. Global Multiomics Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 7.4. Cell Biology
  • 7.4.1. Global Cell Biology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Oncology
  • 7.5.1. Global Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Neurology
  • 7.6.1. Global Neurology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Immunology
  • 7.7.1. Global Immunology Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Multiomics Market: End-use Business Analysis

• 8.1. Segment Dashboard
• 8.2. Global Multiomics Market End-use Movement Analysis
• 8.3. Global Multiomics Market Size & Trend Analysis, by End-use, 2021 to 2033 (USD Million)
• 8.4. Academic and Research Institutes
  • 8.4.1. Global Academic and Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Pharmaceutical & Biotechnology Companies
  • 8.5.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Others
  • 8.6.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Multiomics Market: Regional Estimates & Trend Analysis by Product & Service, Type, Platform, Application, & End-use

• 9.1. Regional Dashboard
• 9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 9.3. North America
  • 9.3.1. North America Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. Key Country Dynamics
    • 9.3.2.2. Competitive Scenario
    • 9.3.2.3. Regulatory Framework
    • 9.3.2.4. U.S. Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3.3. Canada
    • 9.3.3.1. Key Country Dynamics
    • 9.3.3.2. Competitive Scenario
    • 9.3.3.3. Regulatory Framework
    • 9.3.3.4. Canada Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3.4. Mexico
    • 9.3.4.1. Key Country Dynamics
    • 9.3.4.2. Competitive Scenario
    • 9.3.4.3. Regulatory Framework
    • 9.3.4.4. Mexico Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.4. Europe
  • 9.4.1. Europe Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.2. UK
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Competitive Scenario
    • 9.4.2.3. Regulatory Framework
    • 9.4.2.4. UK Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.3. Germany
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Competitive Scenario
    • 9.4.3.3. Regulatory Framework
    • 9.4.3.4. Germany Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.4. France
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Competitive Scenario
    • 9.4.4.3. Regulatory Framework
    • 9.4.4.4. France Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.5. Italy
    • 9.4.5.1. Key Country Dynamics
    • 9.4.5.2. Competitive Scenario
    • 9.4.5.3. Regulatory Framework
    • 9.4.5.4. Italy Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.6. Spain
    • 9.4.6.1. Key Country Dynamics
    • 9.4.6.2. Competitive Scenario
    • 9.4.6.3. Regulatory Framework
    • 9.4.6.4. Spain Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.7. Denmark
    • 9.4.7.1. Key Country Dynamics
    • 9.4.7.2. Competitive Scenario
    • 9.4.7.3. Regulatory Framework
    • 9.4.7.4. Denmark Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.8. Sweden
    • 9.4.8.1. Key Country Dynamics
    • 9.4.8.2. Competitive Scenario
    • 9.4.8.3. Regulatory Framework
    • 9.4.8.4. Sweden Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.9. Norway
    • 9.4.9.1. Key Country Dynamics
    • 9.4.9.2. Competitive Scenario
    • 9.4.9.3. Regulatory Framework
    • 9.4.9.4. Norway Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.2. Japan
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Competitive Scenario
    • 9.5.2.3. Regulatory Framework
    • 9.5.2.4. Japan Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.3. China
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Competitive Scenario
    • 9.5.3.3. Regulatory Framework
    • 9.5.3.4. China Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.4. India
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Competitive Scenario
    • 9.5.4.3. Regulatory Framework
    • 9.5.4.4. India Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.5. Australia
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Competitive Scenario
    • 9.5.5.3. Regulatory Framework
    • 9.5.5.4. Australia Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.6. Thailand
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Competitive Scenario
    • 9.5.6.3. Regulatory Framework
    • 9.5.6.4. Thailand Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.7. South Korea
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Competitive Scenario
    • 9.5.7.3. Regulatory Framework
    • 9.5.7.4. South Korea Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.6. Latin America
  • 9.6.1. Latin America Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.2. Brazil
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Competitive Scenario
    • 9.6.2.3. Regulatory Framework
    • 9.6.2.4. Brazil Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.3. Argentina
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Competitive Scenario
    • 9.6.3.3. Regulatory Framework
    • 9.6.3.4. Argentina Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.7. MEA
  • 9.7.1. MEA Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.2. South Africa
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Competitive Scenario
    • 9.7.2.3. Regulatory Framework
    • 9.7.2.4. South Africa Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.3. Saudi Arabia
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Competitive Scenario
    • 9.7.3.3. Regulatory Framework
    • 9.7.3.4. Saudi Arabia Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.4. UAE
    • 9.7.4.1. Key Country Dynamics
    • 9.7.4.2. Competitive Scenario
    • 9.7.4.3. Regulatory Framework
    • 9.7.4.4. UAE Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key Country Dynamics
    • 9.7.5.2. Competitive Scenario
    • 9.7.5.3. Regulatory Framework
    • 9.7.5.4. Kuwait Multiomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Participant Categorization
• 10.2. Strategy Mapping
• 10.3. Company Market Position Analysis, 2024
• 10.4. Participant's Overview
  • 10.4.1. BD
    • 10.4.1.1. Overview
    • 10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.1.3. Product Benchmarking
    • 10.4.1.4. Strategic Initiatives
  • 10.4.2. Thermo Fisher Scientific Inc.
    • 10.4.2.1. Overview
    • 10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.2.3. Product Benchmarking
    • 10.4.2.4. Strategic Initiatives
  • 10.4.3. Illumina, Inc
    • 10.4.3.1. Overview
    • 10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.3.3. Product Benchmarking
    • 10.4.3.4. Strategic Initiatives
  • 10.4.4. Danaher
    • 10.4.4.1. Overview
    • 10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.4.3. Product Benchmarking
    • 10.4.4.4. Strategic Initiatives
  • 10.4.5. PerkinElmer Inc.
    • 10.4.5.1. Overview
    • 10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.5.3. Product Benchmarking
    • 10.4.5.4. Strategic Initiatives
  • 10.4.6. Shimadzu Corporation
    • 10.4.6.1. Overview
    • 10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.6.3. Product Benchmarking
    • 10.4.6.4. Strategic Initiatives
  • 10.4.7. Bruker
    • 10.4.7.1. Overview
    • 10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.7.3. Product Benchmarking
    • 10.4.7.4. Strategic Initiatives
  • 10.4.8. QIAGEN
    • 10.4.8.1. Overview
    • 10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.8.3. Product Benchmarking
    • 10.4.8.4. Strategic Initiatives
  • 10.4.9. Agilent Technologies, Inc.
    • 10.4.9.1. Overview
    • 10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.9.3. Product Benchmarking
    • 10.4.9.4. Strategic Initiatives
  • 10.4.10. BGI
    • 10.4.10.1. Overview
    • 10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 10.4.10.3. Product Benchmarking
    • 10.4.10.4. Strategic Initiatives